-+ 0.00%
-+ 0.00%
-+ 0.00%

Ladenburg Thalmann Assumes Cellectar Biosciences at Buy, Announces Price Target of $10

Benzinga·05/15/2026 19:31:13
Listen to the news
Ladenburg Thalmann analyst Kevin DeGeeter assumes Cellectar Biosciences (NASDAQ:CLRB) with a Buy rating and announces Price Target of $10.